“…Adipocyte-specific KO of mTORC1 causes lipodystrophy, insulin resistance, and severe hepatic steatosis, but enhances energy expenditure and counteracts high-fat diet (HFD)-induced obesity (22)(23)(24). In BAT, loss of mTORC1 affects the BAT cold-adaptation and reduces BAT mass and lipid content (23,25), while activation of mTORC1 in WAT elevates Ucp1, PPAR coactivator 1 (Pgc1), and Ppar expression (26), suggesting a positive role of mTORC1 in regulating brown and beige adipogenesis. Adipose-specific mTORC2 ablation has little effect on fat cell size or fat mass, but leads to insulin resistance, affects glucose and lipid metabolism, and protects against HFD-induced obesity (19,20,27,28).…”